SEC Form 4 · accession 0001225208-18-013738
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin J. Ballinger
Officer — EVP & Pres, Interven Cardio
Period of report
Sep 24, 2018
Accepted (ET)
Sep 25, 2018 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Sep 24, 2018 | M | 37,430 | $7.39 | A | 109,438 | D | |
| Common StockF2 | Sep 24, 2018 | S | 37,430 | $38.00 | D | 72,008 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $7.39 | Sep 24, 2018 | M | 37,430 | D | — | Feb 28, 2023 | Common Stock | 37,430 | 0 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
- F2Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- F3Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.